Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person. To achieve this, Privia offers a comprehensive suite of services. These include technology and population health tools designed to streamline independent providers' workflows; a Management Services Organization (MSO) that…
18 analysts rate PRVA Buy on consensus.
Consensus price target: $31.35 (+27.7% upside from $24.55)
| Insider | Date | Transaction | Shares | Value |
|---|---|---|---|---|
| Mountcastle David EVP & Chief Financial Officer | Jul 7, 2026 | Sale | 600 | $16.54K |
| Morris Matthew Shawn director | Jul 1, 2026 | Sale | 45,634 | $1.21M |
| Morris Matthew Shawn director | Jul 1, 2026 | Sale | 37,041 | $997.51K |
| Morris Matthew Shawn director | Jun 30, 2026 | Sale | 52,823 | $1.36M |
| Mehrotra Parth director, Chief Executive Officer | May 12, 2026 | Sale | 15,647 | $354.25K |
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2025 | $2.12B | +22.26% | $22.92M |
| 2024 | $1.74B | +4.74% | $14.39M |
| 2023 | $1.66B | +22.19% | $23.08M |
Stock data for PRVA: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics